Sutro Biopharma, Inc. (STRO) Reports FY Loss of $1.78

Sutro Biopharma, Inc. (NASDAQ: STRO) reported FY EPS of ($1.78). Revenue for the year came in at $153.73 million.

For earnings history and earnings-related data on Sutro Biopharma, Inc. (STRO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79